healthcare

cannabis plants

Marijuana Price Slips to $1,988

For the week ended Friday, April 29, the spot price index for a pound of cannabis dropped 0.7% from $2,002 in the prior week to $1,988. The simple average price ...
Read Full Story »
analysis

How Analysts View Stericycle After Earnings

Stericycle Inc. (NASDAQ: SRCL) reported its first-quarter financial results after the markets closed on Thursday. Unfortunately, the results missed earnings expectations and the stock saw a new 52-week low early ...
Read Full Story »
clinical trials

Gilead Results Trip Over Both the Top and Bottom Lines

Gilead Sciences Inc. (NASDAQ: GILD) reported first-quarter financial results after the markets closed on Thursday. The company had $3.03 in earnings per share (EPS) on $7.79 billion in revenue compared ...
Read Full Story »
coins

Bristol-Myers Squibb Offers Up Solid Earnings Beat and Lifts Guidance

Bristol-Myers Squibb Co. (NYSE: BMY) released its first-quarter financial results before the markets opened on Thursday. The company said it had $0.74 in earnings per share (EPS) on $4.4 billion ...
Read Full Story »
white pills

Why AbbVie Earnings Failed to Impress Investors

AbbVie Inc. (NYSE: ABBV) reported its first-quarter financial results before the markets opened on Thursday. The company said it had $1.15 in earnings per share (EPS) on $5.96 billion in ...
Read Full Story »
IPO

Intellia Therapeutics Announces Potential Pricing for IPO

Intellia Therapeutics has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company intends to price its 5 million shares ...
Read Full Story »
cancer

Oncobiologics Announces Potential Pricing for IPO

Oncobiologics has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company expects to price its 5 million shares within ...
Read Full Story »
automatic inspection machine

Spring Bank Pharmaceuticals Scales Back IPO

Spring Bank Pharmaceuticals has registered an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). The company expects to price its 1.154 ...
Read Full Story »
Prescription drugs

Major Pharma Short Interest Remains Mixed, With 1 Massive Drop

The short interest data have been released for the April 15 settlement date. Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through ...
Read Full Story »
biotech word cloud

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the April 15 settlement date. Biotech companies are considered a riskier group of stocks, with big upside and big downside. FDA rulings can ...
Read Full Story »
100 dollar bills

Why Global Pharma Profits Should Keep Rising

With  2016 being a U.S. presidential election year, there has been an endless debate over drug pricing and the government's lack of ability to negotiate with drug companies. If Moody's ...
Read Full Story »
FDA_logo

Why This Isn’t the End of Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Inc. (NASDAQ: CPRX) saw its shares get halved just Tuesday morning alone, following a business update regarding its Lambert-Eaton myasthenic syndrome (LEMS) treatment. The company provided an update ...
Read Full Story »
Test tubes

4 Biotechs That Will Escape Weak Seasonal Trends for the Sector

All sectors of the market tend to have times of the year that are better than others, and biotechnology is no different. Typically each year, the first quarter is the ...
Read Full Story »
Medicine pills

What to Expect When Eli Lilly Reports Earnings

Eli Lilly and Co. (NYSE: LLY) is set to release its first-quarter earnings report before the markets open on Tuesday. Thomson Reuters has consensus estimates of $0.85 in earnings per share ...
Read Full Story »
U Turn

Could This Be the Turnaround That Aralez Pharma Is Looking For?

Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) saw its stock take a solid uptick early on Monday following a key approval in Canada. After a very rough past year, this could be beginning ...
Read Full Story »